Abiopharma

News list

Felli Martin 🟢 acquired 1.2M shares (1 derivative) of Alight, Inc. / Delaware (ALIT) Transaction Date: Mar 25, 2026 | Filing ID: 021535

Full text

News bot March 26, 2026, 10:36 p.m.
🔍 Felli Martin (Executive)

Company: Alight, Inc. / Delaware (ALIT)

Report Date: 2026-03-25
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 1
- Holdings reported: 1
- Total shares acquired: 1,250,000
- Total shares held: 571,360
Detailed Transactions and Holdings:
- Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-03-25 | Code: H | shares_owned_after: 571,360.00
- Acquired 1,250,000 shares of Performance Stock Units (Derivative)
  Date: 2026-03-25 | Code: A | equity_swap_involved: 0 | shares_owned_after: 1,250,000.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2
Footnotes:
- F1: On March 25, 2026, the reporting person was granted 1,250,000 performance stock units. Each performance stock unit represents a contingent right to receive one share of Alight, Inc.'s Class A Common Stock.
- F2: The performance stock units vest and become earned in up to 25% increments based on the achievement of specified stock price performance hurdles during a five-year performance period, beginning on April 1, 2026, and ending on December 31, 2030, and subject to service-based vesting conditions.